These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3010524)

  • 21. Seroprevalence of human T-cell lymphotropic virus type 1 among homosexual men in the United States.
    Manns A; Obrams I; Detels R; Diwan A; Ginzburg HM; Goedert JJ; Blattner WA
    N Engl J Med; 1988 Aug; 319(8):516-7. PubMed ID: 2900465
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunofluorescence in the serological study of HTLV-III/LAV].
    Picchio G; Muchinik G
    Medicina (B Aires); 1986; 46(2):247-8. PubMed ID: 3033429
    [No Abstract]   [Full Text] [Related]  

  • 23. [An epidemic of syphilis among homosexual and bisexual men. Results of tracing the sources of infection].
    Brandrup F; Traulsen E
    Ugeskr Laeger; 1988 Jan; 150(3):141-2. PubMed ID: 3232232
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening for gonorrhea and syphilis in gay bathhouses in Denver and Los Angeles.
    Merino HI; Judson FN; Bennett D; Schaffnit TR
    Public Health Rep; 1979; 94(4):376-9. PubMed ID: 472098
    [No Abstract]   [Full Text] [Related]  

  • 25. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
    Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
    Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men.
    Schechter MT; Boyko WJ; Douglas B; Willoughby B; McLeod A; Maynard M; Craib KJ; O'Shaughnessy M
    CMAJ; 1986 Dec; 135(12):1355-60. PubMed ID: 3022904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-HTLV-III/LAV antibodies in hematology reactives].
    Aznar JA; Monzó E; Mayans J; Granda D; Hurtado F; Curats R
    Sangre (Barc); 1986; 31(2):215-7. PubMed ID: 3014670
    [No Abstract]   [Full Text] [Related]  

  • 28. [Seroepidemiology of the HTLV-III virus in a high-risk Panamanian population. Preliminary report].
    Arosemena JR; Cuevas M; Ulloa E; Guerrero DM; Gómez B; Cantón-Dutary A; Reyes R; Quiroz E; de Britton RM; Brenes MM
    Rev Med Panama; 1986 May; 11(2):124-33. PubMed ID: 3018847
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunosuppression in homosexual men seronegative for HTLV-III.
    Ranki A; Valle SL; Antonen J; Suni J; Jokipii L; Jokipii AM; Saxinger C; Krohn K
    Cancer Res; 1985 Sep; 45(9 Suppl):4616s-4618s. PubMed ID: 3160458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of HTLV-III/LAV antibodies in ex-residents from Angola and Mozambique returning to Portugal before 1979.
    Victorino RM; Maria VA; Jeffries DJ; Pinching A
    Acta Med Port; 1986; 7(1):49-50. PubMed ID: 3014826
    [No Abstract]   [Full Text] [Related]  

  • 31. HTLV-III antibody frequency and severity of lymphadenopathy.
    Bayer H; Bienzle U; Schneider J; Hunsmann G
    Lancet; 1984 Dec; 2(8415):1347. PubMed ID: 6150360
    [No Abstract]   [Full Text] [Related]  

  • 32. [HTLV-III/LAV antibodies in gamma globulin preparations for intravenous use].
    Kaeser A
    Dtsch Med Wochenschr; 1986 Aug; 111(33):1263. PubMed ID: 2427300
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anti-LAV/HTLV-III antibodies in gamma globulin preparations destined for intravenous administration].
    Dickgiesser N; Brenner KP; Mertens T
    Dtsch Med Wochenschr; 1986 Jun; 111(26):1041. PubMed ID: 3013564
    [No Abstract]   [Full Text] [Related]  

  • 34. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 36. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 37. [HTLV-III in patients in a hemodialysis program].
    Cuxart M; Salas M; Aubia J; Lloveras J
    Med Clin (Barc); 1986 Apr; 86(14):611. PubMed ID: 3014239
    [No Abstract]   [Full Text] [Related]  

  • 38. Occurrence of anti-HTLV-III antibodies in Danish high-risk homosexuals in 1982-83--seroconversion rate and risk of AIDS.
    Hofmann B; Platz P; Odum N; Ryder LP; Svejgaard A; Pedersen NS; Nielsen JO; Faber V; Sprechler HH; Oehlenschlager J
    AIDS Res; 1986 Feb; 2(1):1-3. PubMed ID: 3013217
    [No Abstract]   [Full Text] [Related]  

  • 39. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.